Regulation of tumor necrosis factor-α einduced microvascular endothelial cell hyperpermeability by recombinant B-cell lymphoma-extra large

Journal of Surgical Research

Volumn 184, Issue 1, 2013, Pages 628-637

  Sawant, Devendra A ^a   Tharakan, Binu ^b   Wilson, Rickesha L ^b   Stagg, Hayden W ^b   Hunter, Felicia A ^a   Childs, Ed W ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Adherens junction; Apoptotic signaling; B Catenin; Bcl 2 homology domain 3 interacting domain death agonist; BID; Vascular permeability

Indexed keywords

BETA CATENIN; BOVINE SERUM ALBUMIN; CASPASE 3; CASPASE 8 INHIBITOR; FLUORESCEIN ISOTHIOCYANATE; PHALLOIDIN; PROTEIN BCL 2; PROTEIN BCL XL; RECOMBINANT PROTEIN; RHODAMINE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; FLUOROMETRY; IMMUNOFLUORESCENCE; LUNG ENDOTHELIUM; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS FIBER; TISSUES;

EID: 84884674457     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.04.079     Document Type: Article

References (35)

1. Yuan SY, Rigor RR. Regulation of endothelial barrier function. Integrated systems physiology: from molecule to function to disease. San Rafael (CA): Morgan & Claypool Life Sciences; 2010.
2. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2002;39:257.
3. Shankar R, Melstrom KA Jr, Gamelli RL. Inflammation and sepsis: past, present, and the future. J Burn Care Res 2007;28:566.
4. Childs EW, Udobi KF, Hunter FA, Dhevan V. Evidence of transcellular albumin transport after hemorrhagic shock. Shock 2005;23:565.
5. Dewar D, Moore FA, Moore EE, Balogh Z. Postinjury multiple organ failure. Injury 2009;40:912.
6. Namas R, Ghuma A, Hermus L, et al. The acute inflammatory response in trauma/hemorrhage and traumatic brain injury: current state and emerging prospects. Libyan J Med 2009;4:97.
7. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769.
8. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF alpha in pulmonary pathophysiology. Respir Res 2006; 7:125.
9. Campbell MT, Dagher P, Hile KL, et al. Tumor necrosis factor-a induces intrinsic apoptotic signaling during renal obstruction through truncated bid activation. J Urol 2008;180: 2694.
10. Zhao Y, Sui X, Ren H. From procaspase-8 to caspase-8: revisiting structural functions of caspase-8. J Cell Physiol 2010;225:316.
11. Kiechle FL, Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 2002;326:27.
12. Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 2011;351:41.
13. Ezzoukhry Z, Louandre C, François C, et al. The Bcl-2 homology domain 3 (BH3) mimetic ABT-737 reveals the dynamic regulation of Bad, a proapoptotic protein of the Bcl- 2 family, by Bcl-xL. Mol Pharmacol 2011;79:997.
14. Goldblum SE, Hennig B, Jay M, Yoneda K, McClain CJ. Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infect Immun 1989;57:1218.
15. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. Differential effect of MLC kinase in TNF-alphaeinduced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;280:L1168.
16. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD. The role of the microtubules in tumor necrosis factoralphaeinduced endothelial cell permeability. Am J Respir Cell Mol Biol 2003;28:574.
17. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann NY Acad Sci 2008;1123:134.
18. Sawant DA, Tharakan B, Adekanbi A, Hunter FA, Smythe WR, Childs EW. Inhibition of VE-cadherin proteasomal degradation attenuates microvascular hyperpermeability. Microcirculation 2011;18:46.
19. Sawant DA, Tharakan B, Hunter FA, Smythe WR, Childs EW. Role of b-catenin in regulating microvascular endothelial cell hyperpermeability. J Trauma 2011;70:481.
20. Tharakan B, Hellman J, Sawant DA, et al. b-Catenin dynamics in the regulation of microvascular endothelial cell hyperpermeability. Shock 2012;37:306.
21. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008;1778:660.
22. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 2009;77:53.
23. Steinhusen U, Badock V, Baur A, et al. Apoptosis-induced cleavage of b-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem 2000;275:16345.
24. Grinberg M, Sarig R, Zaltsman Y, et al. tBID homooligomerizes in the mitochondrial membrane to induce apoptosis. J Biol Chem 2002;277:12237.
25. Kudla G, Montessuit S, Eskes R, et al. The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved BID is inhibited by the N-terminal fragment. J Biol Chem 2000;275:22713.
26. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 2000;345:271.
27. Eskes R, Desagher S, Antonsson B, Martinou JC. BID induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000;20:929.
28. Kim TH, Zhao Y, Ding WX, et al. BID-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol Biol Cell 2004;15:3061.
29. Gonzalvez F, Pariselli F, Jalmar O, et al. Mechanistic issues of the interaction of the hairpin-forming domain of tBID with mitochondrial cardiolipin. PLoS One 2010;5:e9342.
30. Soustiel JF, Larisch S. Mitochondrial damage: a target for new therapeutic horizons. Neurotherapeutics 2010;7:13.
31. Distelhorst CW, Bootman MD. Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2?) signaling and disease. Cell Calcium 2011;50:234.
32. Kaufmann T, Schlipf S, Sanz J, Neubert K, Stein R, Borner C. Characterization of the signal that directs Bcl-s(L), but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol 2003; 160:53.
33. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ. Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 1995;182:821.
34. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009;15:1126.
35. Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 2011;18:1414.